Journal of Heart and Lung Transplantation

Article	Citations
A growing trend: CFTR modulators for cystic fibrosis lung transplant recipients	469
What's in a name: The importance of lung transplant at Cystic Fibrosis Foundation Accredited Care Centers for patients with Cystic Fibrosis	326
Information for Readers	259
The gift of organ donation as a last wish	194
Brick by brick, BOLT by BOLT: Building the case for DCD lung transplant	148
Editorial Board	121
Will the real high-risk heart transplant recipients please stand up?	113
Ex-vivo lung perfusion: National trends and post-transplant outcomes	110
Piwi-interacting RNAs (piRNAs), potential new liquid biopsy in the immune surveillance of heart transplant recipients	84
Decoding cardiac allograft vasculopathy: Harnessing multimodal imaging to improve prognosis	79
Living donor lobar lung transplantation in children: An impressive Japanese cohort and worldwide implications	71
Donor to recipient age matching in lung transplantation: A European experience	66
Impact of tacrolimus vs cyclosporine on chronic lung allograft dysfunction incidence and allograft survival in the International Society of Heart and Lung Transplantation registry	66
Strategies for bridge to heart transplantation: Percutaneous mitral valve repair and LVAD	64
Residual mitral regurgitation in patients with left ventricular assist device support – An INTERMACS analysis	58
Factors associated with acute limb ischemia in cardiogenic shock and downstream clinical outcomes: Insights from the Cardiogenic Shock Working Group	57
Hemodynamic reserve predicts early right heart failure after LVAD implantation	55
The evaluation of constant coronary artery flow versus constant coronary perfusion pressure during normothermic ex situ heart perfusion	53
Patient factors associated with left ventricular assist device infections: A scoping review	53
Living-donor lobar lung transplantation	49
Table of Contents	49
Editorial Board	48
Editorial Board	47
Implications of and potential solutions for the weekend effect in heart transplantation	46
Editorial Board	45

Information for Readers	43
Lung transplant waitlist outcomes among ABO blood groups vary based on disease severity	43
Disseminated Pulmonary Kaposi Sarcoma After Lung Transplantation: The Increased Risk Donor	40
Pregnancy in PAH: Reality is changing	40
Innate allorecognition in transplantation	39
Assessment of Cerebral Perfusion and Activity during Normothermic Regional Perfusion in a Porcine Model of Donation after Circulatory Death	39
Response to JHLT-D-21-00302 "Failing Fontan – heart or heart-liver transplant: The jury is (still) out?"	38
Table of Contents	38
Retraction notice to ICAM-1 PROMOTES THE ABNORMAL ENDOTHELIAL CELL PHENOTYPE IN CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION	37
Thoraco abdominal normothermic regional perfusion and lung transplantation – is it a safe match?	36
Table of Contents	35
Table of Contents	35
Not just for the birds: The emerging role of B cells in transplant immunology	35
Editorial Board	35
Right Heart Reverse Remodeling Correlates with NT-proBNP Outcomes Among Pulmonary Arterial Hypertension Patients on Combination Therapy	34
(997) Routine Donor Specific Antibody Monitoring in Heart Transplant Recipients - Is There a Role?	34
Editorial Board	34
Table of Contents	33
Table of Contents	33
Right heart failure after left ventricular assist device implantation – from prediction to action	33
Information for Readers	33
(701) Use of Tixagevimab and Cilgavimab (Evusheld) and Subsequent Outcomes of SARS-CoV-2 Infections in Lung Transplant Recipients	33
(506) Characterization of Donor-Derived Cell-Free DNA Results in Cardiac Donation after Brain Death vs. Donation after Cardiac Death	32
Cardiac allograft vasculopathy in pediatric heart transplant recipients does early-onset portend a worse prognosis?	30
Many heart transplant biopsies currently diagnosed as no rejection have mild molecular antibody-mediated rejection-related changes	30
Spectrum of findings on ventilation‒perfusion lung scintigraphy after lung transplantation and association with outcomes	30
Long-Term Complications After Support with Impella 5.0 and 5.5	29
Patient-centered real-world registry analysis of cfLVAD recipients: From survival to freedom from hospitalization and beyond	29
Extra-cardiac management of cardiogenic shock in the intensive care unit	29
Incompleteness of health-related quality of life assessments before left ventricular assist device implant: A novel quality metric	29
CD8+ T cell-mediated rejection of allogenic human-induced pluripotent stem cell-derived cardiomyocyte sheets in human PBMC-transferred NOG MHC double knockout mice	28
Improved 2-Year Heart Transplant Survival with Moderate Hypothermic Donor Heart Preservation in the Guardian Heart Registry	28
Table of Contents	28
Dosing of apixaban with left ventricular assist devices: A need for greater clarity	28
Functional status predicts pediatric heart transplant outcomes: A united network for organ sharing (UNOS) database study	28
Editorial Board	28
Gastroesophageal Reflux is a Risk Factor for the Development of de novo Donor Specific Antibodies after Lung Transplantation	28
Information for Readers	27
Relationship between blood and tissue-based rejection-related transcripts in heart transplantation	27
Prophylactic epinephrine attenuates severe bleeding in lung transplantation patients undergoing transbronchial lung biopsy: Results of the PROPHET randomized trial	27
Information for Readers	27
Table of Contents	27
Cytomegalovirus infection is associated with impaired myocardial flow reserve after heart transplantation	27
Sotrovimab in pediatric cardiac transplant recipients with SARS-CoV2 infection	27
Long term follow-up of the tacrolimus in combination, tacrolimus alone compared (TICTAC) trial	27
Donor transmitted and de novo coronary plaque through the OCT magnifying lens	26
Fifth bivalent omicron BA.4/BA.5 vaccination neutralization of SARS-CoV-2 in heart transplant recipients	26
Priorities for pulmonary hypertension research: A James Lind Alliance priority setting partnership	26
Information for Readers	26
(1222) Identifying Imaging Biomarkers Before the Onset of Chronic Lung Allograft Dysfunction	26

Table of Contents	25
MTHFD2 ablation in T cells protects against heart transplant rejection by perturbing IRF4/PD-1 pathway through the metabolic-epigenetic nexus	25
Editorial Board	25
Table of Contents	25
Adult congenital heart disease patients undergoing mechanical circulatory support: Not all patients are the same	25
Three-year outcomes after bridge to transplantation ECMO—pre- and post-2018 UNOS revised heart allocation system	24
Blockade of BLyS inhibits B-cell responses and antibody production for the prevention of chronic transplant rejection	24
Recipient outcomes with extended criteria donors using advanced heart preservation: Response letter and insights into the data	24
Information for Readers	24
Triaging donor lungs based on a microaspiration signature that predicts adverse recipient outcome	24
Anthropometrics are important to consider in purported sex differences in CTEPH outcomes	23
Fecal Transplant for Recurrent Clostridium difficile Colitis in CF-LVAD Supported Patients	23
Venous thromboembolism in lung transplant recipients real world experience from a high volume center	23
Covid-19 in recipients of heart and lung transplantation: Learning from experience	23
Pseudomonas-dominant microbiome elicits sustained IL-1β upregulation in alveolar macrophages from lung transplant recipients	23
Lung transplantation following donation after thoraco-abdominal normothermic regional perfusion (TA-NRP): A feasibility case study	23
The effect of COVID-19 on transplant function and development of CLAD in lung transplant patients: A multicenter experience	23
Clinical impact and economic burden of post-transplant infections following heart transplantation: A retrospective nationwide cohort study	23
It's not only the pump: Assessment of human factors of wearable components and user experience of patients with left ventricular assist devices	22
Plasma kallikrein predicts primary graft dysfunction after heart transplant	21
Impella 5.5 for Frailty and SCAI D-E Shock: Impact on Post-OHT Oucomes	21
Infective Endocarditis at the Inflow Cannula of Left Ventricular Assist Device After Barefoot Walking	21
Evaluation of Platelet Activation by Flow Cytometry in Contemporary Continuous Flow Left Ventricular Assist Device Support	21
WITHDRAWN	21
Transcriptional Changes in Dilated Cardiomyopathy After LVAD Treatment	21
Lung Transplantation in a Recipient with True Tracheal Bronchus	21
(900) Impact of National OCS Lung Procurement & Management Program on Post-Transplant Survival - Real World Data from the Thoracic Organ Perfusion (TOP) Post-Approval Registry	21
Endothelin-1 Levels in Exercise-Induced Pulmonary Hypertension	21
Recurrent Migration of a Protekduo Right Ventricular Assist Device: A Case Report	20
Combined Heart and Lung Transplantation Across Preformed Donor-Specific Antibodies Using a Peritransplant Desensitization Protocol	20
Combined Heart-Liver Transplantation: Indications, Outcomes, and Risk Factors	20
First North American Experience with The Berlin Heart Active Driver	20
Early Conversion from Tacrolimus- to Everolimus-Based Immunosuppression in Pediatric Heart Transplant Recipients for Renal Insufficiency	20
Exploring Innovative Approaches to Enhance Donor Heart Utilization: Moving Beyond the Ideal Donor Paradigm	20
Outcomes of Concomitant Tricuspid Valve Repair with Contemporary Ventricular Assist Device Implantoutcomes Outcomes of Concomitant Tricuspid Valve Repair with Contemporary Left Ventricular Assist Devi	20
When LVAD Support is Just Too Much - A Case of Accelerated Myocardial Recovery with LVAD	20
Dapagliflozin for Graft Dysfunction After Pediatric Heart Transplant	20
Does HLA Matching in Prior Blood Transfusions Impact Lung Transplant Survival Outcomes?	20
Plasma Proteins Ameliorate Loss of Coronary Vascular Resistance During Working Mode Normothermic Ex-Situ Heart Perfusion	19
Impact of Occurrence of Cardiac Arrest on Post-transplant Survival in Brain-Dead Donors: A French National Cohort Study	19
Donor “Left Ventricular Hypertrophy” is Often Transient and/or Spurious	19
Peri-Operative Strategy Using Central Veno-Arterial Extracorporeal Membrane Oxygenation in Lung Transplantation for Patients with Pulmonary Arterial Hypertension	18
Adults with “Fontan Associated Liver Failure”- Is Combined Heart Liver Transplantation Always Necessary?	18
Living-Donor Single-Lobe Lung Transplantation: A Single-Center Case Series	18
Effective Treatment of MDRA. BaumanniiInfection in 3 Htx Patients: A Single Center Experience	18
Outcomes of Lung Transplantation for Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation Compared with Interstitial Pulmonary Fibrosis	18
Donor Profile Changes with the Lung Composite Allocation Score	17
Serial right heart catheter assessment between balloon pulmonary angioplasty sessions identify procedural factors that influence response to treatment	17
Real-time transcription polymerase chain reaction cycle threshold values as criteria for utilization of incidental COVID-19 positive lung donors	17
Usefulness of Established Risk Scores in Predicting Right Heart Failure Requiring Temporary Right Ventricular Assist Device Support Following Left Ventricular Assist Device Implantation	17
Cell-free DNA beyond a biomarker for rejection: Biological trigger of tissue injury and potential therapeutics	17
Withdrawing extra corporeal membrane oxygenation (ECMO) against a family's wishes: Three permissible scenarios	17
Impact of Perioperative Gabapentinoid Use on Lung Transplant Outcomes	17
Compartment-specific remodeling patterns in end-stage chronic obstructive pulmonary disease with and without severe pulmonary hypertension	17
Editorial Board	17
Navigating between management of pulmonary arterial hypertension and cardiometabolic and pulmonary comorbidities	16
Editorial Board	16
Sacubitril-valsartan vs ACE/ARB in pediatric heart failure: A retrospective cohort study	16
Esophageal Disorders in Lung Transplant Recipients: Association with Chronic Lung Allograft Dysfunction and Survival	16
Information for Readers	16
Lung transplant pathology: No longer through a glass darkly?	16
Impact of complications on survival outcomes in different temporary mechanical circulatory support techniques: A large retrospective cohort study of cardiac surgical and nonsurgical patients	16
Recurrence of pulmonary arterial hypertension 32 months after bilateral lung transplant	16
Impact of anticoagulation intensity on blood transfusion for venoarterial extracorporeal membrane oxygenation during lung transplantation	16
A New Modification for Anastomosing HeartMate 3 Apical Cuff for a Small Left Ventricle	16
Information for Readers	16
Limitations of the inotrope score use as a measure of primary graft dysfunction	16
The lung transplant endobronchial biopsy: A forgotten specimen comes of age	16
What we know we do not know: The Johari window in DCD heart transplantation	16
HIV D+/R+ heart/kidney transplantation: First case report	16
Patients Living with Chronic Lung Allograft Dysfunction (CLAD) Provide Essential Insights for Drug Development	15
Fertility Considerations and Lung Transplantation, a Scoping Review	15
Real World Use of Extracorporeal Photopheresis After Heart Transplantation - Clinical Outcomes from a Seven Centre European Study	15
Significant Reduction of Myocardial Injury Markers After Ischemia Minimization in the First Hour of an Ex Vivo Xeno Working Heart Model	15
Do Temporary Mechanical Circulatory Support Devices Activate Sensitization Pathways in Patients Awaiting Heart Transplantation?	15
Improving Bronchoscopy Safety and Diagnostic Yield in Lung Transplant Recipients	15
Adaptive Changes and Estimated Long-Term Survival After Updated Donor Heart Allocation Policy: A UNOS Database Analysis	15
End of Life in Children on Mechanical Circulatory Support	15
Association of Chronic Proton Pump Inhibitor Use in Lung Transplant Recipients with Long-Term Outcomes: A Retrospective Cohort Study	15
Successful Thrombolytic Therapy in a Suspected Case of HeartMate 3 LVAD Thrombosis	15

(592) The Long-Term Impact of Cmv in Adult Primary Lung Transplant Recipients- 16-Year Single-Center Study	15
(821) Biopsy-Proven Fulminant Myocarditis Requiring Mechanical Circulatory Support Following Third Dose of COVID-19 MRNA Vaccination	15
Can Heart Allografts Protect Simultaneous Kidney Allografts from Antibody Injury?	15
Partial Flow Extracorporeal Life Support Strategy for Refractory Cardiogenic Shock	14
(880) Individual Association of Predicted Left and Right Ventricular Mass Ratios with Survival after Heart Transplantation: A UNOS Database Analysis	14
Outcomes by Severity of Obesity During Extracorporeal Membrane Oxygenation Support for COVID-19	14
(722) Angiotensin II Use in Cardiogenic Shock Patients Supported by Temporary Mechanical Circulatory Support	14
Use of Donor Hearts with Low Ejection Fraction in Pediatric Heart Transplantation: A PHTS Analysis	14
(693) Infection with Covid Variants of Concern in a Lung Transplant Population	14
Defining Metrics for Short Term Success After LVAD Implant: An Analysis of the Society of Thoracic Surgeons Intermacs Registry	14
Decoupling Between Pulmonary Artery Diastolic and Wedge Pressure Following TAVR	14
(699) No Association Between BNT162B2 Vaccine and Graft Rejection Among Lung Transplant Recipients	14
Comparing Bronchoalveolar Lavage Microbiological Culture Positivity Between Right versus Left Single Lung Transplants	14
Outcomes of Patients Bridged to Heart Transplantation with ECMO Following the UNOS Allocation Policy Change	14
(784) Impella 5.5 Use as a Bridge to Transplant in Hereditary Transthyretin Amyloidosis	14
(654) Personalizing Cytomegalovirus Prophylaxis in the First Year after Pediatric Heart Transplantation: Impact of a CMV Cell Mediated Immunity-Based Approach	14
Cardiac Disease Increased Risk of Death and Early Comorbidities Impacting Prognosis of Lung Transplant Recipients with Extreme Ages	14
Direct Lung Procurement with Ongoing Abdominal Normothermic Regional Perfusion	14
Lung Transplant from a DCD Donor with a Previous Symptomatic COVID Infection	14
(904) Early Weight Gain During Ex Vivo Lung Perfusion Can Predict Transplant Suitability and Post-Transplant Outcomes	14
Detection of Directly Alloreactive Graft Antigen-Specific CD4+ T Cells in Peripheral Blood	14
(733) Peripheral Indicators of Dysbiosis in Heart Transplant Recipients (PoD-HTR)	14
The Impact of Geographical Distance on Survival in Adult Cystic Fibrosis Lung Transplant Recipients	14
(635) 24 Hour Outcomes of 689 Hearts and Lungs Recovered by a Specialized Thoracic Organ Recovery Team	14
(873) Batch Replacement of Cellular Perfusate Does Not Improve Outcomes in a Model of 24-Hour Negative Pressure Ventilation Ex-Situ Lung Perfusion with Transplantation	13
Feasibility of Smartphone-Based Physical Activity Tele-Coaching in Lung Transplant Recipients; an Interim Analysis	13
Reduction of Immunosuppression Based on Whole Blood EBV-Viral Loads in Lung Transplant Recipients	13
Cost and Effects of Left Atrial Venous Drainage Cannula Placement in Veno-Arterial ExtraCorporeal Membrane Oxygenation (LAVA ECMO) via Transeptal Puncture for Left Heart Decompression	13
Lower-than-Standard Cutoff Number of Reflux Episodes is Associated with Worse Lung Transplant Outcomes	13
Use of SherpaPak™ CTS for Organ Transportation During Heart Transplantation: National Outcomes from United Kingdom	13
(822) Recurrent Pyogenic Granulomas Complicating a Driveline Site	13
Stem Cell Mobilization by Plerixafor Has an Affirmatory Effect on the Development of Transplant Vasculopathy in a Murine Aortic Allograft Model	13
Symptom-Illness Severity Profiles and Healthcare Use Among Lung Transplant Candidates	13
Donor to Recipient Transmission of Bacterial Pathogens in Relation to Cold Ischemic Time in Lung Transplantation	13
WITHDRAWN	13
Long Term Outcome After Pediatric Lung Transplantation	13
A Transplant Center Experience with Basiliximab Induction Strategies - A Double Edged Sword?	13
LVAD Explantation Using a Double Patch Technique	13
Extending the Transplant Practitioner Role within the National Organ Retrieval Team to Include Organ Care Practitioner	13
Delphipanel on Antimicrobial Stewardship and Management of Clinical Syndromes in Thoracic Organ Transplants and Mechanical Circulatory Device Recipients	13
Clinically Important Differences Are Useful for Interpreting Patient-Reported Outcomes Measurement Information System (PROMIS) Measures After Left Ventricular Assist Device (LVAD) Implantation: Findin	13
The New French Heart Allocation System Has Improved Access to Transplantation in Adolescents	13
(828) WITHDRAWN	13
(856) Extracorporeal Cytokine Hemoadsorption During Orthotopic Heart Transplantation: A Comparative Study	13
Heart Transplantation Utilizing Organs Following Donation After Circulatory Death (DCD)	12
Web-Based Knowledge Translation Tools for Parents of Children with Heart Failure: An Environmental Scan	12
Donor and Recipient Cytokine Profiles Predict Acute Rejection and Graft-Related Survival After Heart Transplantation	12
LKB1 Knockdown Triggered PDGFRβ Signaling Leading to Fibrosis and Development of Chronic Lung Allograft Dysfunction	12
Bronchoalveolar Lavage Fluid (BALF) as a Compartment for Donor-Derived Cell-Free DNA (dd-cfDNA) Assessment in Lung Recipients	12
Breakthrough Infections and Low Mortality Observed in Heart Transplant Recipients Infected with COVID-19 at UC San Diego	12
Sudden Cardiac Arrest After Pediatric Heart Transplantation	12
Using Donor Lungs ≥70 Years of Age for Transplantation - Do Long-Term Outcomes Justify the Use?	12
The Impact of Malnutrition and Body Mass Index on Heart Transplant Outcomes	12
(972) Modified Body Mass Index But Not Conventional Body Mass Index Predicts Mortality after Pulmonary Thromboendarterectomy	12
(1153) Characterization of CD3-Guided Anti-Thymocyte Globulin Dose Minimization for Renal Sparing Induction after Heart Transplant	12
(1159) Sirolimus and Tacrolimus Dosing Requirements in Pediatric Heart Transplant Recipients to Target Combined Trough Levels	12
Randomized Trial of Protective Lung Ventilation in Organ Donors	12
Combining VA-ECMO and Impella (EC-Pella) Before Reperfusion Mitigates Left Ventricular Injury Due to VA-ECMO in Acute Myocardial Infarction	12
Fibrosis of Chronic Lung Allograft Dysfunction After Orthotopic Lung Transplantation is Prevented in the Absence of Secondary Lymphoid Organs in a Mouse Model	12
(979) Advanced Pulmonary Hypertension - Cross Sectional Study	12
Evidence of Inotropic Improvement in LVAD Patients with High I-CARS Score	12
(1161) Impact of Extended Mycophenolate Dose Modifications on Chronic Lung Allograft Dysfunction Incidence after Lung Transplant	12
(1162) Outcomes and Immunosuppression of Combined Liver-Lung Transplantation: A Single Center Experience	12
(1202) Alemtuzumab Induction Spares Donor Tissue Resident Memory T Cells after Lung Transplantation	11
(67) Screening for Donor Lung Pulmonary Emboli During Ex-Vivo Lung Perfusion	11
(1157) Evaluation of Hyperbilirubinemia During Glecaprevir/pibrentasvir and Azole Antifungal Coadministration after Cardiothoracic Transplant	11
(28) Artificial Intelligence to Predict Death or Transplant in ATTR Amyloidosis Cardiomyopathy	11
(36) Molecular Drivers of Tissue Resident Memory T Cell Formation in Lung Allografts	11
Challenges in Heart Transplantation During COVID-19 Pandemic in Brazil	11
(64) Emerging Racial Differences in Heart Transplant Waitlist Outcomes for Patients on Temporary Mechanical Circulatory Support	11
(1206) Clinical Implications of Microbiome on Acute Rejection in Lung Transplant Recipients	11
(1185) Plasma Donor-Derived Cell-Free DNA as a Predictor of Freedom from Chronic Lung Allograft Dysfunction More Than 3 Years after Lung Transplant	11
(18) Role of Endothelial-to-Mesenchymal Transition in Chronic Thromboembolic Pulmonary Hypertension (CTEPH)	11
(1176) Do We Know Patient Preferences? Improving Advance Care Planning in Post-Lung Transplant Patients	11
Is There Heterogeneity on Outcome of Hospitalized Heart Transplant Patients with COVID-19 Infection Across the US?	11
(1188) Assessment of Dd-cfDNA Between Stable Single and Double Lung Recipients	11
Managing Contemporary AMR with a 4-Tiered Treatment Protocol: A Single-Center Experience	11
(1207) Anellovirus: A Novel Marker for Overimmunosuppression and Risk of Infection in Lung Transplant Recipients	11
(1155) Safe and Effective Early Use of Betablockers after Pediatric Heart Transplantation	11
(1169) Outcome of Enoxaparin Bridging in Left Ventricular Assist Devices (LVAD) in an Ambulatory Setting: A Continuation Study at Cedars Sinai Medical Center (CSMC)	11
(1180) A Case of Successful Lung Transplantation Following 10 Months of Mechanical Ventilator Dependence	11
Outcomes of COVID-19 in Heart Transplant Recipients	11
(55) Genetic Engineering for Combined Early and Long-Term Immunomodulation in the Donor Lung after Transplantation	11
(454) Disseminated Coccidioidomycosis from Orthotopic Heart Transplant Donor Allograft	10
(139) Polymorphism T300a in Atg16l1 is Associated with Post-Transplant Neutropenia in Lung Transplant Recipients	10
(131) Diagnostic Performance of MMDx in Real World Heart Transplant Population: A Single Center Experience	10
(1257) Lung Volume Change Analysis in Lung Transplantation Using a Three-Dimensional Image Analysis System	10
(1245) Lack of Correlation Between Both Percent and Absolute Count Dd-CfDNA and Primary Graft Dysfunction	10
(1270) Thermal Preconditioning During EVLP Reduces T Lymphocytes and Increases Monocytes and Neutrophils Contents in the Perfusion Solution	10
(1266) Isolation and Characterization of Osteopontin-Expressing Pulmonary Macrophages Associated with Chronic Lung Allograft Dysfunction in Humans	10
(135) Glycoprotein (GP)Ibα Protein Expression is Reduced in HeartMate 3 Patients with Non-Surgical Bleeding Complications Within the First 3 Months	10
(1258) A Single-Center Retrospective Study of Patients Undergoing Combined Liver-Lung Transplantation (LLT)	10
(273) Postoperative Renal Failure in Patients Undergoing Isolated Heart Transplantation: What are the Outcomes?	10
(282) Comparing Patients Bridged to Transplant with a Fully Magnetically Levitated Left Ventricular Assist Device Before and after the UNOS/OPTN Allocation Change: An STS-Intermacs Registry Analysis	10
(120) Heart Preservation with the Organ Care System in Extended Criteria Donor Hearts: A Single Center Experience	10